[go: up one dir, main page]

GB2003030A - Drug composition with beta-adrenergic receptor blocking agent - Google Patents

Drug composition with beta-adrenergic receptor blocking agent

Info

Publication number
GB2003030A
GB2003030A GB7834358A GB7834358A GB2003030A GB 2003030 A GB2003030 A GB 2003030A GB 7834358 A GB7834358 A GB 7834358A GB 7834358 A GB7834358 A GB 7834358A GB 2003030 A GB2003030 A GB 2003030A
Authority
GB
United Kingdom
Prior art keywords
beta
blocking agent
adrenergic receptor
drug composition
receptor blocking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB7834358A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIMES Societa Italiana Medicinali e Sintetici SpA
Original Assignee
SIMES Societa Italiana Medicinali e Sintetici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE180506A external-priority patent/BE858198A/en
Application filed by SIMES Societa Italiana Medicinali e Sintetici SpA filed Critical SIMES Societa Italiana Medicinali e Sintetici SpA
Publication of GB2003030A publication Critical patent/GB2003030A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB7834358A 1977-08-29 1978-08-23 Drug composition with beta-adrenergic receptor blocking agent Withdrawn GB2003030A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE180506A BE858198A (en) 1977-08-29 1977-08-29 PHARMACEUTICAL COMPOSITIONS BASED ON ANXIOLYTIC MEDICINAL PRODUCTS AND INHIBITORS OF THE ADRENERGIC SYSTEM

Publications (1)

Publication Number Publication Date
GB2003030A true GB2003030A (en) 1979-03-07

Family

ID=3843036

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7834358A Withdrawn GB2003030A (en) 1977-08-29 1978-08-23 Drug composition with beta-adrenergic receptor blocking agent

Country Status (5)

Country Link
US (1) US4190654A (en)
JP (1) JPS5449333A (en)
DE (1) DE2752384A1 (en)
GB (1) GB2003030A (en)
IT (1) IT1118226B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468391A (en) * 1982-06-25 1984-08-28 Ayerst, Mckenna & Harrison, Inc. Combination of β-adrenoceptor antagonists and anxiolytic agents
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7766013B2 (en) * 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7458374B2 (en) * 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7090830B2 (en) * 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20040105818A1 (en) * 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) * 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JP2007516404A (en) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ, インコーポレイテッド Optically or electrically ignited built-in heating unit and drug supply unit using the same
US7540286B2 (en) * 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (en) * 2004-08-12 2012-11-21 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heating unit
US20100006092A1 (en) * 2004-08-12 2010-01-14 Alexza Pharmaceuticals, Inc. Aerosol Drug Delivery Device Incorporating Percussively Activated Heat Packages
US9079030B2 (en) * 2004-12-22 2015-07-14 G. Blake Holloway Systems and methods for balancing and maintaining the health of the human autonomic nervous system
EP2121088B1 (en) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
KR102852740B1 (en) 2018-02-02 2025-08-29 알렉스자 파마스티칼즈, 인크. Electrical Condensation Aerosol Device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867529A (en) * 1970-08-24 1975-02-18 Giorgio Ferrari Tranquilizing and anti-anxiety pharmaceutical compositions

Also Published As

Publication number Publication date
US4190654A (en) 1980-02-26
DE2752384A1 (en) 1979-03-15
IT7824023A0 (en) 1978-05-30
IT1118226B (en) 1986-02-24
JPS5449333A (en) 1979-04-18

Similar Documents

Publication Publication Date Title
ZA775370B (en) Sustained release pharmaceutical composition
JPS53109934A (en) Pharmaceutical composition
ZA761727B (en) Beta-adrenergic receptor blocking agents
GB2003030A (en) Drug composition with beta-adrenergic receptor blocking agent
JPS5484022A (en) Pharmaceutical composition
IL55342A0 (en) Radiation-detecting camera and collimator for use therein
JPS5399334A (en) Antiitumor agent
ZA781773B (en) Instillation composition
JPS53107425A (en) Antiioestrogen acting agent
PH15193A (en) Pharmaceutical composition
GB2002758B (en) Neuromuscular blocking agents
JPS5369822A (en) Pharmaceutical agent
GB2002229B (en) Pharmaceutical composition
GB2021409B (en) Pharmaceutical composition
JPS5394038A (en) Pharmaceutical composition
JPS5486607A (en) Solid pharmaceutical composition
JPS53101520A (en) Pharmaceutical composition
ZA786259B (en) Therapeutic composition
JPS53136530A (en) Antiisweat agent
JPS55100314A (en) Continuously releasing drug composition
JPS545045A (en) Pharmaceutical composition
GB2000506B (en) Fibre-treating agent
JPS5413480A (en) Releasing agent
SU725541A3 (en) Herbicidic agent
JPS542338A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)